指南与共识慢性肾脏病

2018 KDIGO 慢性肾脏病丙型肝炎指南实施:亚洲峰会会议报告

2018 Kidney Disease: Improving Global Outcomes (KDIGO) Hepatitis C in Chronic Kidney Disease Guideline Implementation: Asia Summit Conference Report.
指南 / 共识 · Kidney Int Rep · 2020-05-21

2018年KDIGO发布慢性肾脏病(CKD)丙型肝炎病毒(HCV)感染预防、诊断、评估和治疗指南。为评估该指南在亚洲的实施情况,KDIGO在香港召开HCV实施峰会,来自8个东南亚国家或地区的肾脏科、肝科和护理专家参会,描述区域实践模式、识别实施障碍并制定克服策略。

要点

  • 2018 KDIGO指南涵盖CKD患者HCV感染的预防、诊断、评估和治疗。
  • 亚洲8个中高收入国家或地区参会,描述实践模式并识别指南实施障碍。
  • 会议制定策略以克服亚洲及全球的指南实施障碍。

核心结论

  • 2018 KDIGO HCV in CKD指南已发布,但亚洲地区实施存在障碍,需制定策略克服。

研究设计与样本

  • KDIGO在香港召开HCV实施峰会,参会者来自8个东南亚国家或地区:中国大陆、香港、日本、马来西亚、新加坡、韩国、台湾和泰国。
  • 参会者包括肾脏科医生、肝科医生和护士顾问。

主要发现

  • 参会者描述了与KDIGO HCV in CKD指南相关的区域实践模式。
  • 参会者识别了实施指南的障碍。
  • 参会者制定了在亚洲及全球克服障碍的策略。

临床怎么用

  • 肾脏科医生应参考2018 KDIGO指南管理CKD患者HCV感染,并注意区域实施障碍。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In 2018, Kidney Disease: Improving Global Outcomes (KDIGO) published a clinical practice guideline on the prevention, diagnosis, evaluation, and treatment of hepatitis C virus (HCV) infection in chronic kidney disease (CKD). The guideline synthesized recent advances, especially in HCV therapeutics and diagnostics, and provided clinical recommendations and suggestions to aid healthcare providers and improve care for CKD patients with HCV. To gain insight into the extent that the 2018 guideline has been adopted in Asia, KDIGO convened an HCV Implementation Summit in Hong Kong. Participants included nephrologists, hepatologists, and nurse consultants from 8 Southeast Asian countries or regions with comparable high-to-middle economic ranking by the World Bank: mainland China, Hong Kong, Japan, Malaysia, Singapore, South Korea, Taiwan, and Thailand. Through presentations and discussions, meeting participants described regional practice patterns related to the KDIGO HCV in CKD guideline, identified barriers to implementing the guideline, and developed strategies for overcoming the barriers in Asia and around the world.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Li PK, Bavanandan S, Mohamed R, et al. 2018 Kidney Disease: Improving Global Outcomes (KDIGO) Hepatitis C in Chronic Kidney Disease Guideline Implementation: Asia Summit Conference Report. Kidney Int Rep. 2020. PMID: 32775812. doi:10.1016/j.ekir.2020.05.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。